Bioequivalent as judged by the FDA does not at all mean identical. ETA: The fact that generics are not “literally identical” is probably the most important sci

Bioequivalent as judged by the FDA does not at all mean identical. ETA: The fact that generics are not “literally identical” is probably the most important scientific, policy, and commercial consideration in that industry. FDA has to determine whether the benefits of lower costs justify the potentially lower efficacy, and set bounds for how different a generic can be and still count as “bioequivalent.”